Pharmacokinetic similarity demonstrated after crushing of the elbasvir/grazoprevir fixed-dose combination tablet for HCV infection

BACKGROUND: Finding a suitable treatment for HCV patients with swallowing disorders is still a major challenge. In practice, direct-acting antivirals are crushed without knowledge of adequate absorption. Crushing can alter drug exposure, possibly leading to treatment failure, development of resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Pijnenburg, Daniëlle W M, van Seyen, Minou, Abbink, Evertine J, Colbers, Angela, Drenth, Joost P H, Burger, David M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443725/
https://www.ncbi.nlm.nih.gov/pubmed/32544221
http://dx.doi.org/10.1093/jac/dkaa230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443725/
https://www.ncbi.nlm.nih.gov/pubmed/32544221
http://dx.doi.org/10.1093/jac/dkaa230

Ejemplares similares